Last Updated On 4/12/2022 8:38:58 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: ROME Therapeutics |
| Recipient: You |
| Company: Gerson Lehman Group (GLG) |
| Recipient: You |
| Company: Guidepoint Global, LLC |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| No Relationships to Disclose |
|
|
| Patents, Royalties, Other Intellectual Property |
| Please describe: I am co-inventors on a filed patent for the use of interleukin 33 inhibition for the treatment of cancer, fibrosis and inflammation (PCT/US21/40725). This patent is licensed to DermBiont |
| Recipient: You |
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|